Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performed (List separately in addition to code for primary procedure)

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 93463 refers to the administration of a pharmacologic agent during a heart catheterization procedure, which is a critical intervention used to assess and treat various cardiovascular conditions. This code specifically encompasses the administration of agents such as inhaled nitric oxide, intravenous nitroprusside, dobutamine, milrinone, or other similar medications. The procedure involves a comprehensive evaluation of hemodynamic measurements, which are essential for understanding the patient's cardiovascular status. Prior to the administration of the pharmacologic agent, baseline hemodynamic measurements are obtained to establish a reference point. These measurements may include various parameters such as cardiac index, cardiac output, central venous pressure, mean arterial pressure, preload, afterload, pulmonary artery pressure, pulmonary capillary wedge pressure, pulmonary vascular resistance, right ventricular pressure, stroke index, stroke volume, and systemic vascular resistance. Following the administration of the pharmacologic agent, additional hemodynamic measurements are taken to assess the patient's response to the treatment. This process may involve administering an additional dose of the same or a different pharmacologic agent, with subsequent hemodynamic assessments performed to compare and interpret the results. The physician is responsible for analyzing these measurements and providing a written report detailing the findings. It is important to note that this code is reported separately in addition to the primary procedure of heart catheterization and may only be billed once per session.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The CPT® Code 93463 is indicated for use in specific clinical scenarios where the administration of a pharmacologic agent is necessary to evaluate hemodynamic responses during a heart catheterization procedure. The following conditions may warrant the use of this code:

  • Heart Failure: Patients experiencing acute or chronic heart failure may require pharmacologic agents to assess cardiac function and optimize treatment.
  • Cardiogenic Shock: In cases of cardiogenic shock, the administration of agents like dobutamine or nitroprusside can help evaluate hemodynamic stability and guide further management.
  • Severe Hypertension: Patients with severe hypertension may need pharmacologic intervention to assess the impact on hemodynamic parameters.
  • Assessment of Cardiac Function: The procedure is indicated for patients requiring detailed evaluation of cardiac output and other hemodynamic measurements to inform treatment decisions.

2. Procedure

The procedure associated with CPT® Code 93463 involves several critical steps to ensure accurate assessment and administration of pharmacologic agents. The following procedural steps are outlined:

  • Step 1: Baseline Hemodynamic Measurements Before the administration of any pharmacologic agent, baseline hemodynamic measurements are obtained. This initial assessment is crucial as it establishes a reference point for evaluating the patient's cardiovascular status. Measurements taken may include cardiac index, cardiac output, central venous pressure, mean arterial pressure, and other relevant parameters.
  • Step 2: Administration of Pharmacologic Agent Following the baseline assessment, the pharmacologic agent is administered intravenously or via inhalation, depending on the specific agent used. This step is essential for evaluating the agent's effects on the patient's hemodynamics.
  • Step 3: Intra-Procedure Hemodynamic Measurements During the administration of the pharmacologic agent, additional hemodynamic measurements are performed. These measurements help to monitor the immediate effects of the agent on the patient's cardiovascular system.
  • Step 4: Post-Administration Hemodynamic Measurements After the pharmacologic agent has been administered, further hemodynamic assessments are conducted to evaluate the patient's response. This may include repeating the measurements taken prior to administration to determine any changes in the hemodynamic profile.
  • Step 5: Additional Dosing and Repeat Measurements If necessary, an additional dose of the same pharmacologic agent or a different agent may be administered. Subsequent hemodynamic measurements are then repeated to assess the effects of the new dose on the patient's condition.
  • Step 6: Interpretation and Reporting The physician interprets the collected hemodynamic data, comparing the results from before, during, and after the administration of the pharmacologic agent. A comprehensive written report detailing the findings and any clinical implications is then generated for documentation purposes.

3. Post-Procedure

After the completion of the pharmacologic agent administration and associated hemodynamic measurements, the patient may require monitoring to assess recovery and response to the treatment. The physician will review the findings from the hemodynamic assessments and determine any necessary follow-up actions or adjustments to the treatment plan. It is essential to document all findings accurately, as this information is critical for ongoing patient management and may influence future therapeutic decisions. The code 93463 may only be reported once in conjunction with the primary heart catheterization procedure, ensuring that all relevant data is captured for billing and compliance purposes.

Short Descr DRUG ADMIN & HEMODYNMIC MEAS
Medium Descr MEDICATION ADMIN & HEMODYNAMIC MEASURMENT
Long Descr Pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performed (List separately in addition to code for primary procedure)
Status Code Active Code
Global Days ZZZ - Code Related to Another Service
PC/TC Indicator (26, TC) 0 - Physician Service Code
Multiple Procedures (51) 0 - No payment adjustment rules for multiple procedures apply.
Bilateral Surgery (50) 0 - 150% payment adjustment for bilateral procedures does NOT apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 0 - Payment restriction for assistants at surgery applies to this procedure...
Co-Surgeons (62) 0 - Co-surgeons not permitted for this procedure.
Team Surgery (66) 0 - Team surgeons not permitted for this procedure.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Items and Services Packaged into APC Rates
Type of Service (TOS) 2 - Surgery
Berenson-Eggers TOS (BETOS) P2F - Major procedure, cardiovascular-Other
MUE 1
CCS Clinical Classification 47 - Diagnostic cardiac catheterization, coronary arteriography

This is an add-on code that must be used in conjunction with one of these primary codes.

33477 MPFS Status: Active Code APC C Transcatheter pulmonary valve implantation, percutaneous approach, including pre-stenting of the valve delivery site, when performed
93451 MPFS Status: Active Code APC J1 ASC G2 Right heart catheterization including measurement(s) of oxygen saturation and cardiac output, when performed
93452 MPFS Status: Active Code APC J1 ASC G2 Left heart catheterization including intraprocedural injection(s) for left ventriculography, imaging supervision and interpretation, when performed
93453 MPFS Status: Active Code APC J1 ASC G2 Combined right and left heart catheterization including intraprocedural injection(s) for left ventriculography, imaging supervision and interpretation, when performed
93456 MPFS Status: Active Code APC J1 ASC G2 Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right heart catheterization
93457 MPFS Status: Active Code APC J1 ASC G2 Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography and right heart catheterization
93458 MPFS Status: Active Code APC J1 ASC G2 Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed
93459 MPFS Status: Active Code APC J1 ASC G2 Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography
93460 MPFS Status: Active Code APC J1 ASC G2 Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed
93461 MPFS Status: Active Code APC J1 ASC G2 Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography
93580 MPFS Status: Active Code APC J1 CPT Assistant Article Illustration for Code Percutaneous transcatheter closure of congenital interatrial communication (ie, Fontan fenestration, atrial septal defect) with implant
93581 MPFS Status: Active Code APC J1 CPT Assistant Article Illustration for Code Percutaneous transcatheter closure of a congenital ventricular septal defect with implant
93582 MPFS Status: Active Code APC J1 Percutaneous transcatheter closure of patent ductus arteriosus
93593 MPFS Status: Carrier Priced APC J1 Right heart catheterization for congenital heart defect(s) including imaging guidance by the proceduralist to advance the catheter to the target zone; normal native connections
93594 MPFS Status: Carrier Priced APC J1 Right heart catheterization for congenital heart defect(s) including imaging guidance by the proceduralist to advance the catheter to the target zone; abnormal native connections
93595 MPFS Status: Carrier Priced APC J1 Left heart catheterization for congenital heart defect(s) including imaging guidance by the proceduralist to advance the catheter to the target zone, normal or abnormal native connections
93596 MPFS Status: Carrier Priced APC J1 Right and left heart catheterization for congenital heart defect(s) including imaging guidance by the proceduralist to advance the catheter to the target zone(s); normal native connections
93597 MPFS Status: Carrier Priced APC J1 Right and left heart catheterization for congenital heart defect(s) including imaging guidance by the proceduralist to advance the catheter to the target zone(s); abnormal native connections
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
XU Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service
GC This service has been performed in part by a resident under the direction of a teaching physician
AQ Physician providing a service in an unlisted health professional shortage area (hpsa)
76 Repeat procedure or service by same physician or other qualified health care professional: it may be necessary to indicate that a procedure or service was repeated by the same physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 76 to the repeated procedure or service. note: this modifier should not be appended to an e/m service.
78 Unplanned return to the operating/procedure room by the same physician or other qualified health care professional following initial procedure for a related procedure during the postoperative period: it may be necessary to indicate that another procedure was performed during the postoperative period of the initial procedure (unplanned procedure following initial procedure). when this procedure is related to the first, and requires the use of an operating/procedure room, it may be reported by adding modifier 78 to the related procedure. (for repeat procedures, see modifier 76.)
79 Unrelated procedure or service by the same physician or other qualified health care professional during the postoperative period: the individual may need to indicate that the performance of a procedure or service during the postoperative period was unrelated to the original procedure. this circumstance may be reported by using modifier 79. (for repeat procedures on the same day, see modifier 76.)
80 Assistant surgeon: surgical assistant services may be identified by adding modifier 80 to the usual procedure number(s).
AS Physician assistant, nurse practitioner, or clinical nurse specialist services for assistant at surgery
CR Catastrophe/disaster related
GV Attending physician not employed or paid under arrangement by the patient's hospice provider
GW Service not related to the hospice patient's terminal condition
LC Left circumflex coronary artery
LD Left anterior descending coronary artery
Q1 Routine clinical service provided in a clinical research study that is in an approved clinical research study
Q6 Service furnished under a fee-for-time compensation arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area
RC Right coronary artery
RT Right side (used to identify procedures performed on the right side of the body)
XE Separate encounter, a service that is distinct because it occurred during a separate encounter
XS Separate structure, a service that is distinct because it was performed on a separate organ/structure
Date
Action
Notes
2017-01-01 Changed Moderate (Conscious) Sedation flag removed. See new Moderate Sedation category.
2013-10-14 Changed Guideline information changed. Deleted codes 93563 & 93564 and Added Codes 93563 & 93564 to 93530, 93531, 93532, 93533 Effective 2013-10-14 per AMA 2014 corrections document posted 2014-03-24
2013-01-01 Changed Guideline information changed.
2011-01-01 Added Added
Code
Description
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"